Clinical Trial Update: Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS [Phase 3]

View source ↗

Summary

A Phase 3 double-blind, placebo-controlled trial evaluating levetiracetam in adults with partial-onset seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-onset Seizures

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy, Partial | Phase 3 | Status: COMPLETED